Duragesic recall issued due to leaking fentanyl gel

Yesterday, Johnson & Johnson issued a Duragesic recall for all lots of their 25 microgram-per-hour fentanyl patches. Some of the powerful painkilling patches could contain a cut in the lining of the internal reservoir where the fentanyl gel is stored. This may allow the gel to leak directly onto the skin, resulting in serious and potentially fatal problems, such as respiratory depression or a possible fentanyl overdose.

>>INFORMATION: Duragesic Recall Lawsuits

The announcement marks the fifth Duragesic recall since 1994. Hundreds of fentanyl overdose deaths have been suffered by users of the patch which could be attributed to inadequate warnings or production problems since the medication was approved by the FDA. This recall appears to have been caused by a manufacturing defect where the fentanyl patches were not properly put in place when they were cut.

>>INFORMATION: Fentanyl Patch Problems

The Duragesic patch is a powerful opioid painkiller, which is worn on the skin for extended periods of time. It is intended to treat severe chronic pain in people who are tolerant of such narcotics, such as cancer patients. However, it has also been prescribed frequently “off-label” for unapproved uses, such as management of temporary post-surgical pain or headaches. The FDA has issued several health alerts to physicians warning about the risk of overdose associated with the use of the fentanyl patch.

This weeks Duragesic recall applies to millions of 25 mcg/hr fentanyl patches which have an expiration date of December 2009 or before. About 80 lots of the patches have been distributed in the United States and 15 lots were distributed in Canada, with 400,000 units in each lot. The recall does not apply to other fentanyl patches with strengths of 12.5, 50, 75 and 100 micrograms-per-hour.

The Duragesic recall was issued by PriCara, which is a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., a unit of the mega-corporation Johnson & Johnson. Some generic forms of the patch sold by Sandoz, Inc., a unit of Novartis AG, were also impacted by the recall. The Sandoz fentanyl patches were manufactured by the same company which produced the defective brand name Duragesic patches.

Individuals who have 25 microgram-per-hour fentanyl patches have been advised to check the box or foil pouch to determine if it has an expiration date of December 2009 or earlier. Although the cut edge in defective patches can be seen upon opening the sealed foil pouch, users should not attempt to handle the potentially defective patches. If the skin does come into direct contact with fentanyl gel which leaks out, the area of the skin should be thoroughly rinsed with large amounts of water, but soap should not be used.

DURAGESIC RECALL LAWSUITS

The fentanyl lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Duragesic lawsuits on behalf of individuals who suffered an overdose death after use of a fentanyl patch. To have a potential claim evaluated, request a free consultation.

3 Responses to:

“Duragesic recall issued due to leaking fentanyl gel”

  1. Second Fentanyl Patch Recall Issued | Fentanyl Patch Lawsuits | Legal News & Updates Blog - Saiontz, Kirk & Miles Says:

    [...] >>PRIOR POST (2/13/2008): Duragesic Pain Patch Recall [...]

  2. Dorothy N. Says:

    Does this recall affect the flat “blue boxed” patches? When I get my RX filled I ask for those instead of the bubble type gel inside.

  3. Generic Fentanyl Pain Patch Recall - Fentanyl Lawyers | Legal News & Updates Blog - Saiontz, Kirk & Miles Says:

    [...] Johnson & Johnson issued a recall for 32 million of their 25 microgram-per-hour brand name Duragesic pain patches, as well as generic fentanyl pain patches sold by Sandoz, Inc., due to a manufacturing problem [...]

Leave a Reply

  1. (required)
  2. (valid email required)
  3. I authorize the above comments to be posted on this page?
  1. If you wish to have an attorney review your comments and contact you to review a potential case, please provide additional contact information.
    The information below will not be published and will be kept 100% confidential.
 

cforms contact form by delicious:days

Additional Information and Lawsuit Resources

MRI Lawsuit
MRI Contrast Lawsuits

Gadolinium contrast used during MRI and MRA could cause Nephrogenic Systemic Fibrosis (NSF) among those with kidney problems.

More MRI Lawsuit Info

Chantix Lawsuits
Chantix Suicide Problems

Anti-smoking drug Chantix side effects could increase the risk of suicide or suicidal thoughts which the manufacturer failed to adequately warn about.

More Chantrix Lawsuit Info

Yamaha Rhino Rollover Lawsuits
Yamaha Rhino Rollovers

The Yamaha Rhino is prone to rollover due to design defects. Lack of safety features and proper warnings have resulted in serious fractures and crush injuries for many riders.

More Yamaha Rhino Lawsuit Info

Shoulder Surgery Pump
Shoulder Pain Pump Lawsuits

Infusion pain pumps used following arthroscopic shoulder surgery have been linked to painful and debilitating cartilage loss.

More PAGCL Info